Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Impact of the COVID-19 Pandemic on Adherence to Prescribed DAPT: A Window into Acute Cardiovascular Care
2) This is an international perspective, from @gabrielsteg, #Stefan_James, @SanjitSJolly, @MkosiborodMD, & @MarcBonaca. Their #roundtable...
ERA 2022 Congress Update: SGLT-2 Inhibitors and Diabetic Kidney Disease
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in...
Hyperlipidemia Management in the Primary Care Setting
2a) This is the next instalment of @cardiomet_CE's 10-part #tweetorial foundational series on #lipid management! It is accredited for #CME/CE and...
Identifying the Highest Risk PAD Patients
2) This educational program is accredited for 0.5h CE/#CME & is intended for healthcare professionals. Author disclosures & Accreditation...
NLA Scientific Statement on Statin Intolerance: A New Definition and Guidance on Managing Statin Intolerant Patients
1b) The new #gduidelines can be found at 🔓 https://t.co/06ldtc4m2A along with an infographic 🔓https://t.co/4JwRfqXEEw— cardio-met (@cardiomet_CE)...
Risk-adjusted Duration of Anticoagulation for VTE
1b) BTW, Dr. Arya is Theme Leader for #VTE at the upcoming #ISTH2022 congress in London that kicks off this weekend. It will be the most important...
Evaluating Post-Intervention Treatment Options for PAD
2) The @cardiomet_ce program is supported by educational grants from AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly...
Preventing Hyperkalemia from Derailing Evidence-Based CV Care
2) This #accredited #tweetorial series on #kidneydisease #hyperkalemia is supported by an independent educational grant from AstraZeneca and is...
Optimizing Medical Therapy for Patients with HFrEF
1b) @ValleAlfonso is Jefe Servicio Cardiologia, Área del Corazón, Marina Salud. Denia Servicio de Cardiología Hospital La Salud, Valencia. He is a...
Challenging Case Presentations for the Management of Patients with Cardiometabolic Disease
2) She is a member of UKCPA Diabetes & Endocrinology committee @UKCPADiabetes & works across #diabetes, #endocrinology, &...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.